Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Foulkes Cancer Genetics LDI, |
RCV001200994 | SCV001371972 | pathogenic | DICER1-related tumor predisposition | 2019-07-01 | criteria provided, single submitter | curation | ACMG criteria met: PVS1, PM2, PM7 |
Labcorp Genetics |
RCV001200994 | SCV002123114 | pathogenic | DICER1-related tumor predisposition | 2020-12-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln330*) in the DICER1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DICER1 are known to be pathogenic (PMID: 19556464, 21266384). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of DICER1 syndrome (PMID: 29938629). ClinVar contains an entry for this variant (Variation ID: 933007). For these reasons, this variant has been classified as Pathogenic. |
Department of Clinical Genetics, |
RCV001200994 | SCV005689653 | pathogenic | DICER1-related tumor predisposition | 2025-01-24 | criteria provided, single submitter | clinical testing | The following ACMG criteria have been used in classification: PM2_SUP; PVS1; PS4_SUP |